Discover 870 paid clinical trials in Tuscaloosa, Alabama. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 870
A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)
for
Ovarian Neoplasms, Ovarian Cancer
Location: Birmingham AL, Germantown TN, Atlanta GA, Nashville TN,
Sponsor: Merck Sharp & Dohme LLC
Sex: Female
Age: 18+
Code: NCT07318558
Phase 3, Recruiting
Early Life Exposures Among Children With Sickle Cell Disease
Dose-Expansion Study of Low Dose Post-Transplant Cyclophosphamide/Tacrolimus/Ruxolitinib for Graft-versus-Host Disease (GVHD) Prophylaxis in Myeloablative Allogeneic Peripheral Blood Stem Cell Transplantation
An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)
for
Progressive Pulmonary Fibrosis,
Location: Birmingham AL, Atlanta GA, Nashville TN, Statesville NC,
Sponsor: Avalyn Pharma Inc.
Sex: All
Age: 18+
Code: NCT06951217
Phase 2, Recruiting
Dabrafenib and Trametinib for BRAF V600 Mutant Low-Grade Gliomas
for
BRAF V600 Mutation, Low-grade Glioma, Low Grade Glioma of Brain,
Location: Birmingham AL, Memphis TN, Gainesville FL, St Louis MO,
Sponsor: University of California, San Francisco
Sex: All
Age: 1 - 25
Code: NCT07110246
Phase 2, Recruiting
Clinical Study to Evaluate the Safety and Effectiveness of Arcevo LSA
for
Aortic Arch Aneurysm, Aortic Arch Dissection,
Location: Birmingham AL, Atlanta GA, Gainesville FL, Houston TX,
Sponsor: Artivion Inc.
Sex: All
Age: 18 - 70+
Code: NCT07089576
Recruiting
A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)
for
Cervical Cancer
Location: Birmingham AL, Atlanta GA, Knoxville TN, Shreveport LA,
Sponsor: Merck Sharp & Dohme LLC
Sex: Female
Age: 18+
Code: NCT07216703
Phase 3, Recruiting
High-energy Human Milk Diets in the First Two Weeks After Birth to Reduce BPD in Extremely Preterm Infants
for
Extreme Prematurity, Enteral Nutrition,
Location: Birmingham AL
Sponsor: University of Alabama at Birmingham
Sex: All
Age: 0
Code: NCT07307612
Phase 1, Phase 2, Recruiting
Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD)
for
Chronic Kidney Disease(CKD), Type 2 DM,
Location: Birmingham AL, Houston NC, St. Petersburg FL, Durham NC,
Sponsor: Duke University
Sex: All
Age: 18+
Code: NCT06906627
Recruiting
Implementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD) (Program 2)
for
Chronic Kidney Disease(CKD), Type 2 DM,
Location: Birmingham AL, St. Petersburg FL, Houston TX, Durham NC,
Sponsor: Duke University
Sex: All
Age: 18+
Code: NCT06906640
Recruiting
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
for
Pancreatic Cancer, PDAC,
Location: Birmingham AL, Atlanta GA, Nashville TN,
Sponsor: Revolution Medicines, Inc.
Sex: All
Age: 18+
Code: NCT07252232
Phase 3, Recruiting
TulmiSTAR-02: A Phase I/II Open-label Study of Tulmimetostat in Combination With Darolutamide vs. Darolutamide, and Tulmimetostat With Abiraterone in Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
for
Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)